BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8077139)

  • 1. Humoral hypercalcemia of malignancy associated with ameloblastoma in a horse.
    Rosol TJ; Nagode LA; Robertson JT; Leeth BD; Steinmeyer CL; Allen CM
    J Am Vet Med Assoc; 1994 Jun; 204(12):1930-3. PubMed ID: 8077139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameloblastic carcinoma ex ameloblastoma of the mandible with malignancy-associated hypercalcemia.
    Cox DP; Muller S; Carlson GW; Murray D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):716-22. PubMed ID: 11113817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism caused by a functional parathyroid adenoma in a horse.
    Peauroi JR; Fisher DJ; Mohr FC; Vivrette SL
    J Am Vet Med Assoc; 1998 Jun; 212(12):1915-8. PubMed ID: 9638193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohyperparathyroidism in a mare associated with squamous cell carcinoma of the vulva.
    Karcher LF; Le Net JL; Turner BF; Reimers TJ; Tennant BC
    Cornell Vet; 1990 Apr; 80(2):153-62. PubMed ID: 2318041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of parathyroid hormone-related protein in a squamous cell carcinoma arising from mature cystic teratoma causing humoral hypercalcemia of malignancy.
    Takeuchi K; Murata K; Funaki K; Kitazawa S; Kitazawa R
    Gynecol Oncol; 2000 Dec; 79(3):504-7. PubMed ID: 11104629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive rostral mandibulectomy for treatment of ameloblastoma in a horse.
    Mendez-Angulo JL; Tatarniuk DM; Ruiz I; Ernst N
    Vet Surg; 2014 Feb; 43(2):222-6. PubMed ID: 24392727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: case report.
    Tsunematsu R; Saito T; Iguchi H; Fukuda T; Tsukamoto N
    Gynecol Oncol; 2000 Feb; 76(2):218-22. PubMed ID: 10637074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia and high serum parathyroid hormone-related protein concentration in a horse with multiple myeloma.
    Barton MH; Sharma P; LeRoy BE; Howerth EW
    J Am Vet Med Assoc; 2004 Aug; 225(3):409-13, 376. PubMed ID: 15328717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huge ameloblastoma associated with hypercalcemia, leukocytosis, and elevated tumor markers via production of parathyroid hormone-related protein and granulocyte colony-stimulating factor.
    Ota Y; Aoki T; Otsuru M; Hirabayashi K; Nakamura N; Tsukinoki K
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1380-5. PubMed ID: 21824706
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral hypercalcemia of malignancy.
    Martin TJ
    Bone Miner; 1988 Apr; 4(1):83-9. PubMed ID: 3056542
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercalcemia secondary to a pseudoparathormone-secreting ameloblastoma.
    McGuirt WF; Scruggs MS; Koufman JA
    Arch Otolaryngol; 1981 Aug; 107(8):487-90. PubMed ID: 6264904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
    Cisneros G; Lara LF; Crock R; Whittier FC
    South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia associated with malignancy in a horse.
    McCoy DJ; Beasley R
    J Am Vet Med Assoc; 1986 Jul; 189(1):87-9. PubMed ID: 3733508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcaemia and the synthesis of interleukin-1 by an ameloblastoma.
    Macpherson DW; Hopper C; Meghji S
    Br J Oral Maxillofac Surg; 1991 Feb; 29(1):29-33. PubMed ID: 2004073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.
    Schöttker B; Heinz W; Weissinger F; Sözener K; Eck M; Seufert J
    Haematologica; 2006 Dec; 91(12 Suppl):ECR45. PubMed ID: 17194651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy.
    McKee RL; Caulfield MP
    Pept Res; 1989; 2(2):161-6. PubMed ID: 2520752
    [No Abstract]   [Full Text] [Related]  

  • 17. Adamantinoma of the equine mandible, a case report.
    Hanselka DV; Roberts RE; Thompson RB
    Vet Med Small Anim Clin; 1974 Feb; 69(2):157-60. PubMed ID: 4492809
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy.
    Sanders JL; Chattopadhyay N; Kifor O; Yamaguchi T; Brown EM
    Biochem Biophys Res Commun; 2000 Mar; 269(2):427-32. PubMed ID: 10708570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.